Senate Bill 1495 amends Tennessee Code Annotated to expand the list of pharmaceutical companies involved in opioid-related legal provisions. Specifically, it replaces references to "Purdue Pharma L.P." with "Purdue Pharma L.P., Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc." in Section 20-13-203. Additionally, in Section 33-11-103(p), the bill updates the language to include these same companies, ensuring they are recognized in the context of opioid-related legal matters.

The bill also includes a severability clause, which states that if any part of the act is found to be invalid, the remaining provisions will still be enforceable. This act is set to take effect immediately upon becoming law, emphasizing the urgency of addressing the opioid crisis in Tennessee.

Statutes affected:
Introduced: 20-13-203, 33-11-103(p), 33-11-103